[OT] VRX / ICN Pharma: That ribavirin ended up being synergistic with interferon and becoming part of the standard of care in chronic hepatitis C was an amazing stroke of luck. ICN licensed ribavirin to both SGP and Roche, and each of those companies bundled ribavirin with its house brand of interferon in a maneuver that made users raving mad.
In addition to the chicanery you alluded to, Panic essentially embezzled money from the company and ICN had to sue to get it back.
News 
Market Data 
Discover 
AI
